UBS Group’s CollPlant Biotechnologies CLGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-24,074
| Closed | -$62.1K | – | 8954 |
|
|
2025
Q1 | $62.1K | Buy |
24,074
+1,866
| +8% | +$4.81K | ﹤0.01% | 6134 |
|
|
2024
Q4 | $79.9K | Buy |
22,208
+10,261
| +86% | +$36.9K | ﹤0.01% | 5792 |
|
|
2024
Q3 | $59.3K | Buy |
11,947
+4,805
| +67% | +$23.9K | ﹤0.01% | 5505 |
|
|
2024
Q2 | $35.5K | Buy |
7,142
+2,362
| +49% | +$11.7K | ﹤0.01% | 5807 |
|
|
2024
Q1 | $25.6K | Buy |
+4,780
| New | +$25.6K | ﹤0.01% | 5637 |
|
|
2023
Q4 | – | Sell |
-5,690
| Closed | -$31.7K | – | 8121 |
|
|
2023
Q3 | $31.7K | Sell |
5,690
-858
| -13% | -$4.78K | ﹤0.01% | 5437 |
|
|
2023
Q2 | $53.4K | Sell |
6,548
-1,456
| -18% | -$11.9K | ﹤0.01% | 5377 |
|
|
2023
Q1 | $56.2K | Buy |
8,004
+964
| +14% | +$6.77K | ﹤0.01% | 5286 |
|
|
2022
Q4 | $58.8K | Sell |
7,040
-2,126
| -23% | -$17.8K | ﹤0.01% | 5461 |
|
|
2022
Q3 | $62K | Buy |
9,166
+1,652
| +22% | +$11.2K | ﹤0.01% | 5070 |
|
|
2022
Q2 | $60K | Buy |
7,514
+4,085
| +119% | +$32.6K | ﹤0.01% | 4774 |
|
|
2022
Q1 | $38K | Sell |
3,429
-1,837
| -35% | -$20.4K | ﹤0.01% | 5724 |
|
|
2021
Q4 | $86K | Buy |
+5,266
| New | +$86K | ﹤0.01% | 5371 |
|
|
2021
Q3 | – | Sell |
-2,010
| Closed | -$43K | – | 8393 |
|
|
2021
Q2 | $43K | Buy |
2,010
+832
| +71% | +$17.8K | ﹤0.01% | 5499 |
|
|
2021
Q1 | $16K | Buy |
+1,178
| New | +$16K | ﹤0.01% | 6539 |
|
|
2020
Q4 | – | Sell |
-273
| Closed | -$2K | – | 7369 |
|
|
2020
Q3 | $2K | Sell |
273
-422
| -61% | -$3.09K | ﹤0.01% | 6754 |
|
|
2020
Q2 | $7K | Buy |
+695
| New | +$7K | ﹤0.01% | 6356 |
|
|
2019
Q4 | – | Sell |
-5,304
| Closed | -$21K | – | 7025 |
|
|
2019
Q3 | $21K | Buy |
5,304
+3,521
| +197% | +$13.9K | ﹤0.01% | 5741 |
|
|
2019
Q2 | $8K | Buy |
+1,783
| New | +$8K | ﹤0.01% | 6299 |
|
|
2019
Q1 | – | Sell |
-3,316
| Closed | -$14K | – | 6879 |
|
|
2018
Q4 | $14K | Sell |
3,316
-6,515
| -66% | -$27.5K | ﹤0.01% | 6108 |
|
|
2018
Q3 | $50K | Buy |
+9,831
| New | +$50K | ﹤0.01% | 5272 |
|